T. Nathan Yoganathan MSc, PhD

Dr. T. Nathan Yoganathan is currently the President and Chief Scientific Officer of KalGene Pharmaceuticals. Dr. Yoganathan is a university and industrial research scientist, turned entrepreneur who became an experienced CEO, having successfully launched a public biotechnology company. He has over twenty-five years of experience in scientific research in cell signaling and gene expression technology, and has published several articles, and is an inventor of many patents.

Dr. Yoganathan is the recipient of numerous awards, including ones from the Natural Sciences and Engineering Research Council of Canada, and the Thyroid Foundation of Canada. He serves on a number of advisory boards for both government and industry, including the CIHR Strategic Training Program in the Bioinformatics Advisory Board, BIOTECanada’s Emerging Companies Advisory Board, and the Ontario Research Fund Advisory Board. He was elected as a Fellow of the Royal Society of Biology. Dr. Yoganathan was a faculty member of the Department of Medicine at the University of Toronto, and was affiliated with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital. He holds a B.Sc. (Honours) from the University of North London, a M.Sc. from the University of Sussex, and a Ph.D. from the University of Oslo.